library.uns.ac.id digilib.uns.ac.

id

DAFTAR PUSTAKA

Aldasouqi S.A., Gossain V.V. 2008. Haemoglobin A1c: past, present, and future.
Ann Saudi Med. 28: 411-419
Al-Geffari M., Ahmad N.A., Al-Sharqawi A.H., Youssef A.M., Al-Naqeb D., Al-
Rubeaan K. 2013. Risk factors for thyroid dysfunction among type 2 diabetic
patients in a highly diabetes mellitus prevalent society. Hindawi. Article ID
417920: 1-6
Al-Wazzan H.T., Daban A.H., Askar R.A., El-Shazly. 2010. Prevalence and
associated factor of thyroid dysfunction among type 2 diabetic patients,
Kuwait. Bull.Alex.Fac.Med. 46(2): 141-148
Alzubaidy G.H.H., Hussein A.T.A., Aljibouri A.H.M. 2015. Relationship between
leptin and thyroid hormones in type 2 diabetes mellitus patients. J Bab Unv.
23(2): 703-713
Anveetha P., Rao K.P., Chittimoju V.K. 2015. Study of thyroid profile in patients
with type 2 diabetes mellitus. IJPBS. 5(1): 24-30
Arkray. 2015. ADAMS Lite HA-8380V Quick Guide. Arkray global business. Inc.: 1-
4
Bandaru P., Shankar A. 2011. Association between plasma leptin levels and diabetes
mellitus. Metab Syndr Relat Disord. 9(1): 19–23
Bandeira S.D.M., Da Fonseca L.J.S., Guedes G.D.S., Rabelo, L.A., Goulart
M.O.F., Vasconcelos S.M.L. 2013. Oxidative stress as an underlying
contributor in the development of chronic complications in diabetes mellitus.
Int. J. Mol. Sci. 14: 3265-3284
Barnett, P.S., Braunstein, G.D. 2010. Diabetes Mellitus, hlm. 728-751. In Andreoli,
T.E., Benjamin, I.J., Griggs, R.C., Wing, E.J. (edt). Cecil Essentials of
Medicine. 8th edition. Philadelphia: Elsevier Inc.
Biondi B. 2012. Natural history, diagnosis and management of subclinical thyroid
dysfunction. Best Pract Res Clin Endocrinol Metab. 26(4): 431-446.
Bonert V., Friedman T.C. 2010. The thyroid glands. In: Andreoli T.E., Benjamin I.J.,
Griggs R.C., Wing E.J. (eds). Cecil Essentials of Medicine. 8th edition.
Philadelphia: Elsevier Inc., hal.593-601
Bishop M.L., Fody E.P., Schoeff L.E. 2013. Diabetes mellitus. In: Bishop M.L (eds).
Clinical Chemistry: Principles, Tecniques, Correlation. 7th edition, USA:
Lippincott Williams and Wilkins., hal. 304-310
Biomerieux. 2015a. Vidas TSH English. Vidas TSH, No. Katalog 30 400, hal. 1-7
Biomerieux. 2015b. Vidas FT3 English. Vidas FT3, No. Katalog 30 402, hal. 1-5
Biomerieux. 2015c. Vidas FT4 English. Vidas FT3, No. Katalog 30 401, hal. 1-5
Biorad. 2015. Liquicheck diabetes control. USA, hal 1-2
Bloomgarden Z.T. 2008. Glycemic control in diabetes: a tale of three studies.
Diabetes Care. 31(9): 1913-1919
Burtis C.A., Bruns D.E. 2015. Diabetes. In: Sawyer B.G. (edt). Tietz Fundamental of
Clinical Chemistry and Molecular Diagnostic, USA: Elsevier Inc., hal. 608-
631
Campos C. 2012. Chronic hyperglycemia and glucose toxicity: pathology and
clinical sequelae. Postgrad Med J. 124(6): 1-8
Campos C., Casado A. 2015. Oxidative stress, thyroid dysfunction & down
syndrome. Indian J Med Res. 142: 113-119

94
library.uns.ac.id 95
digilib.uns.ac.id

Cho J.H., Kim H.J., Lee J.H., Park I.R., Moon J.S., Yoon J.S., Lee K.I., et al. 2016.
Poor glycemic control is associated with the risk of subclinical
hypothyroidism in patients with type 2 diabetes mellitus. Korean J Intern
Med. 31(4): 703–711
Demers L.M., Spencer C.A. 2002. Laboratory medicine practice guidelines:
Laboratory support for the diagnosis of thyroid disease. N.A.C.B. 13: 5-42
Dahlan M.S. 2014. Statistik untuk Kedokteran dan Kesehatan. Edisi ke-6. Jakarta:
Epidemiologi Indonesia, hal. 257-270
Demitrost L., Ranabir S. 2012. Thyroid dysfunction in type 2 diabetes mellitus: A
retrospective study. Indian J Endocrinol Metab. 16(2): 334–335
DEPKES. 2008. Pedoman Praktik Laboratorium Kesehatan yang Benar (Good
Laboratory Practice). Jakarta: Departemen Kesehatan: hal. 95-104
Duncan R.E., Ahmadian M., Jaworski J., Sarkadi-Nagy E., Sul H.S. 2007.
Regulation of lipolysis in adipocytes. Annu Rev Nutr. 27: 79–101
Duran A.O., Anil C., Gursoy A., Nar A., Inanc M., Bozkurt O., Tutuncu N.B. 2014.
Thyroid volume in patients with glucose metabolism disorders. Arq Bras
Endocrinol Metab. 58(8):824-827
Ekoe J., Zimmet P.Z. 2008. Diagnosis and clasification. In: Ekoe J., Rewers M.,
Williams R., Zimmet P.Z. (eds). In: The Epidemiology of Diabetes Mellitus.
2nd edition. UK: John Willey & Sons Ltd., hal. 11-30
Flier J.S., Harris M., Hollenberg A.N. 2000. Leptin, nutrition, and the thyroid: the
why, the wherefore, and the wiring. J Clin Invest. 105(7): 859-861
Forbes J.M., Cooper M.E. 2013. Mechanisms of diabetic complications. Physiol Rev.
93: 137–188
Fournier J.P., Yin H., Yu O.H.Y., Azoulay L. 2014. Metformin and low levels of thyroid-
stimulating hormone in patients with type 2 diabetes mellitus. CMAJ. 186(15):
1138-1145
Furukawa S., Yamamoto S., Todo Y., Maruyama K., Miyake T., Ueda T., Niiya T.,
et al. 2014. Association between subclinical hypothyroidism and diabetic
nephropathy in patients with type 2 diabetes mellitus. Endocrine Journal. 61
(10): 1011-1018
Ganda O.P. 2010. Dyslipidemia: Pathogenesis and managesment. In: Poretsky, L
(edt). Principles of Diabetes Mellitus, 2nd edition, US: Springer., hal. 435-456
Garber J.R., Gharib H., Hennessey J.V., Klein I., Mechanick J.I., Pessah-Pollack R.,
Singer P.A., et al. 2012. Clinical practice guidelines for hypothyroidism in
adults: cosponsored by the american association of clinical endocrinologists
and the american thyroid association. Endocr Pract. 18(6): 1-45
Garg A., Vanderpump M.P.J. 2013. Subclinical thyroid disease Br.Med.Bull. 107:
101–116
Gomez-Perez F.J., Aguilar-Salinas C.A., Almeda-Valdes P., Cuevas-Ramos D.,
Garber I.L., Rull J.A. 2010. HbA1c for the diagnosis of diabetes mellitus in a
developing country. Arch Med Res. 41: 302-308
Gordon S.M., Davidson W.S., Urbina E.M., Dolan L.M., Heink A., Zang H., Lu
L.J., et al. 2013. Effects of type 2 diabetes on lipoprotein composition and
arterial stiffness in male youth. Diabetes. 62: 2958–2967
Gereben B., Zavacki A.M., Ribich S., Kim B.W., Huang S.A., Simonides W.S.,ld A.
Z., et al. 2008. Cellular and molecular basis of deiodinase-regulated thyroid
hormone signaling. Endocr Rev. 29(7): 898-938
library.uns.ac.id 96
digilib.uns.ac.id

Gupta M., Sharma N., Ali Z., Yadav N. 2014. Status of serum free fatty acid (FFA)
level in obese person and its association with dm type-II. I.J.S.N. 5 (4): 616-
618
Hage M., Zantout M.S., Azar S.T. 2011. Thyroid disorders and diabetes mellitus. J
Thyroid Res. Article ID 439463: 1-7

Hajer G.R., Haeften T.W., Visseren F.L.J. 2008. Adipose tissue dysfunction in
obesity, diabetes, and vascular diseases. Eurheartj. 29: 2959–2971
Han C., He C., Xia X., Li Y., Shi X., Shan Z., Teng W. 2015. Subclinical
hypothyroidism and type 2 diabetes: a systematic review and meta-analysis
Plos One. 10(8): 1-22
Haque S., Siddiqui M.R. 2013. Clinical significance of glycated hemoglobin
(HbA1c). AKMMC J. 4(1): 3-5
Harris R.J. 1985. A primer of multivariate statistics. 2nd edition. New York:
Academic Press
Henrich H.R. 2009. HbA1c—Glycated Hemoglobin and Diabetes Mellitus. 1st
edition, Bremen: UNI-MED., hal. 57-73
Huang S.A., Neves L.A.C. 2010. Thyroid hormone metabolism. In: Brent, G.A.
(edt). Thyroid Function Testing. New York: Springer., hal. 1-16
Institute for Health Metrics and Evaluation. 2014. Global prevalence of smoking
(percentage of smokers). JAMA. 311(2):183-192
Instrumentation Laboratory. 2015. Serachem control level 1. Milano: 1-3
Jindal S., Gupta S. 2012. Endocrine and metabolic role of adipose tissue in
pathogenesis of diabetes mellitus. In: Tripathy B.B., Chandalid H.B. (eds).
Research Society for Study of Diabetes in Inidia (RSSDI) Textbook of
Diabetes Mellitus, volume 1. 2nd edition, New Delhi: Joypee Brothers Medical
publishers Ltd., hal. 277-283
Kahn M.A. 2007. Type 2 Diabetes Proposed Pathogenesis.
http://ocw.tufts.edu/Content/51/lecturenotes/673764/674515. (diunduh 12 Juni
2016)
Khan M.I, Weinstock R.S. 2007. Carbohydrates. In McPherson RA, Pincus MR.
(eds). Henry’s Clinical Diagnosis and Management by Laboratory Methods. ,
21th edition, China: Saunders Elsivier, hal. 185-199
Khurana A., Dhoat P., Jain G. 2016. Prevalence of thyroid disorders in patients of
type 2 diabetes mellitus. JIACM. 17(1): 12-15
LabCorp, 2014. Thyroid cascade testing differential laboratory diagnosis of thyroid
dysfunction.https://www.labcorp.com/.EdosPortlet/TestMenuLibrary?libName
=File+Library&compName=L964 (diunduh tanggal 29 September 2016)
LeFevre M.L. 2015. Screening for thyroid dysfunction: U.S. preventive services task
force recommendation statement. Ann Intern Med. 162(9): 641-650
Little R.R., Roberts W.L. 2009. A review of variant hemoglobins interfering with
hemoglobin a1c measurement. J Diabetes Sci Technol. 3(3):446-451
Maia A.L., Goemann I.M., Meyer E.L.S., Wajner S.M. 2011. Deiodinases: the
balance of thyroid hormone Type 1 iodothyronine deiodinase in human
physiology and disease. J Endocrinol. 209: 283–297
Mancini A., Di Segni C., Raimondo S., Olivieri G., Silvestrini A., Meucci E., Currò
D. 2016. Thyroid hormones, oxidative stress, and inflammation. Hindawi,
2016(6757154): 1-12
Marchetti P. 2009. Advanced glycation end products (AGEs) and their receptors
(RAGEs) in diabetic vascular disease. Medicographia. 31:257-265
library.uns.ac.id 97
digilib.uns.ac.id

Matfin G. 2015. Disorders of endocrine control of growth and metabolism. In: Porth,
C.M (edt). Essentials of Pathophysiology, Concepts of Altered Health States.
4th edition, Philadelphia: Wolters Kluwer., hal. 753-793
Meyerovitch J., Rotman-Pikielny P., Sherf, M. 2007. Serum thyrotropin
measurements in the community: five-year follow-up in a large network of
primary care physicians. Arch Intern Med. 167(14): 1533-1538
Muscogiuri G., Sorice G.P., Mezza T., Prioletta A., Lassandro A.P., Pirronti T., Casa
S.D., et al. 2013. High-normal TSH values in obesity: is it insulin resistance or
adipose tissue's guilt?. Obesity. 21(1): 101-106
Nicholas, A. 2014. Type 2 diabetes mellitus and thyroid dysfunction: an intertwined
duo. AJDM. 22(2): 5-7
Ozougwu J.C., Obimba K.C., Belonwu C.D., Unakalamba C. B. 2013. The
pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus.
Physiol. Pathophysiol 4(4): 46-57
Palma, C.C., Pavesi, M., Nogueira, V.G., Clemente, E.L.S., Vasconcellos,
M.D.F.B.M.P., Pereira Júnior, L.C., Pacheco, F.F., et al. 2013. Prevalence of
thyroid dysfunction in patients with diabetes mellitus. DMSjournals. 5 (58): 1-
5
PERKENI. 2015. Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus Tipe 2
Di Indonesia 2015. PERKENI, Jakarta: hal. 1-85
Petrosyan L. 2015. Relationship between high normal TSH levels and metabolic
syndrome components in type 2 diabetic subjects with euthyroidism. JCTE. 2:
110-113
Ranasinghe C., Gamage P., Katulanda P., Andraweera N., Thilakarathne S.,
Tharanga P. 2013. Relationship between body mass index (BMI) and body fat
percentage, estimated by bioelectrical impedance, in a group of Sri Lankan
adults: a cross sectional study. BMC Public Health. 13(797): 1-8
Ray S., Ghosh S. 2016. Thyroid disorders and diabetes mellitus: double trouble. J
Dia Res Ther. 2(1): 1-7
Reddy S.A., Sachan A., Srinivasa Rao P.V.L.N., Mohan A. 2012. Clinical
applications of glycosylated haemoglobin. J Clin Sci Res 2:22-33.
Régnier C. 2009. Famous French diabetics. Medicographia. 31(3): 316-323.
Rewers M., Hamman R.F. 1995. Risk factors for non-insulin dependent diabetes. In:
Haris M.I. (edt). Diabetes in America, 2nd edition, NIH publication., hal. 179-
221
Rifai N., Warnick G.R, 2006. Lipid, lipoproteine, apolipoproteine, and other cardiac
risk factor In: Burtis, C.A. (edt). Tietz Textbook of Clinical Chemistry and
Molecular Diagnostic. 4th edition, USA: Elsevier Saunders., hal. 940-961
Sacks D.B. 2006. Carbohidrates. In: Burtis, C.A. (edt). Tietz Textbook of Clinical
Chemistry and Molecular Diagnostic. 4th edition, USA: Elsevier Saunders.,
hal. 879-891
Saikumar P., Sudha D., Chandraselvi E. 2014. Body Mass Index Changes in Patients
with Type 2 Diabetes Mellitus. WASJ. 30(10): 1238-1242
Sarath R., Rajkumar B. 2011. Role of leptin in diabetes mellitus. JLS. 1(2): 209-214
Sathish R., Mohan V. 2003. Diabetes and thyroid diseases - a review. Int. J. Diab.
Dev. Countrie. 23: 120-123
Sekisui Medical Diagnostic. 2015. Daiichi Pure Chemicals. Tokyo: 1-2
Seufert J. 2004. Leptin effects on pancreatic cell gene expression and function.
Diabetes. 53 (1): 152–158
library.uns.ac.id 98
digilib.uns.ac.id

Soewondo P., Ferrario A., Tahapary D.L. 2013. Challenges in diabetes management
in Indonesia: a literature review. Global Health. 9 (63): 1-17
Suzuki Y., Nanno M., Gemma R., Yoshimi T. 1992. Plasma free fatty acids,
inhibitor of extrathyroidal conversion of T4 To T3 and thyroid hormone
binding inhibitor in patients with various nonthyroidal illness. Endocrinol
Japon. 39 (5): 445-453
Tan J., Gibson W.T. 2015. Leptin and adiponectin: examining their clinical
significance in obesity. Utmj. 92(2): 1-5
Teramoto T., Sasaki J., Ishibasi S., Birou S., Daida H., Dohi S., Egusa G. 2012.
Diagnostic criteria for dyslipidemia. Executive summary of the Japan
Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of
atherosclerotic cardiovascular diseases in Japan-2012 version. JAT. 20(8):
655-660
Tripathy B.B., Tripathy D. 2012. Pathogenesis of type 2 diabetes mellitus. In:
Tripathy B.B., Chandalid H.B. (eds). Research Society for Study of Diabetes
in Inidia (RSSDI) Textbook of Diabetes Mellitus, volume 1. 2nd edition, New
Delhi: Joypee Brothers Medical publishers (P) Ltd., hal. 223-250
Turki K.M., Ahmed H.S., Saifullah P.H. 2012. Leptin and insulin resistance in type
2 diabetic iraqi male patients. Ijaers. 1(3): 232-234
Tziomalos K., Charsoulis F. 2004. Endocrine Effects of Tobacco Smoking. Clin
Endocrinol. 61(6): 13-21
United Kingdom Prospective Diabetes Study (UKPDS) Group. 1995. : UKPDS 13:
relative efficacy of randomly allocated diet, sulphonylurea, insulin, or
metformin in patients with newly diagnosed non-insulin dependent diabetes
followed for three years. BMJ. 310:83–88
Vanderpump M.P.J. 2011. The epidemiology of thyroid disease. Br.Med.Bull. 99:
39–51
Vanderpump M.P., Tunbridge W.M., French J.M., Appleton D., Bates D, Clark F.,
Grimley E.J., et al. 1995. The incidence of thyroid disorders in the
community: a twenty-year follow-up of the Whickham Survey. Clin
Endocrinol (Oxf). 43(1): 55-68
Vlad M., Timar B., Vlad A., Timar R. 2015. Antithyroid therapy improves glycemic
control in hyperthyroid type 1 diabetes mellitus patients. RJDNMD. 22(4):
411-418
Wang C. 2013. The relationship between type 2 diabetes mellitus and related thyroid
diseases. J Diabetes Res. 2013(390534): 1- 9
Weykamp C. 2013. HbA1c: a review of analytical and clinical aspects. Ann Lab Med
33: 393-400
World Health Organization. 2006a. Definition and Diagnosis of Diabetes Mellitus
and Intermediate Hyperglycemia. Geneva: WHO Document Production
Services, hal, 1-48
World Health Organization. 2006b. Global database on body mass index.
http://apps.who.int/IMT/index.jsp?introPAGEs=intro_3.html (diunduh 12 Juni
2016)
World Health Organization. 2010. WHO Guidelines on Drawing Blood: Best
Practices in Phlebotomy. Geneva: WHO Document Production Services, hal,
9-23
Wajner S.M., Maia L. 2012. New insights toward the acute non-thyroidal illness
syndrome. Fendo. 3(8): 1-7
library.uns.ac.id 99
digilib.uns.ac.id

Warner M.H., Beckett G.J. 2010. Mechanisms behind the non-thyroidal illness
syndrome: an update. J Endocrinol. 205: 1-13
Williams G.R., Bassett J.H.D. 2011. Deiodinases: the balance of thyroid hormone
local control of thyroid hormone action: role of type 2 deiodinase. J
Endocrinol. 209: 261–272
Yang J.K., Liu W., Shi J., Li Y.B. 2010. An association between subclinical
hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic
patients. Diab.Care. 33(5): 1018-1020
Yen P.M. 2001. Physiological and molecular basis of thyroid hormone action. Phys
Rev. 81: 1097-1142
Zimmerman R.S. 2014. Diabetes mellitus: control and complication. In: Stoller J.K.,
Nielsen C., Buccola J., Brateanu A. (eds), The Cleaveland Clinic Foundation
Intensive Review Of Internal Medicines, 6th edition, Philadelphia: Wolters
Kluwer, hal. 249-251